Comparison of Two Microdilution Methods for Testing Susceptibility of Candida spp. to Voriconazole

Journal of Clinical Microbiology

Volumn 42, Issue 2, 2004, Pages 899-902

  Linares, Maria José ^a,b   Charriel, Guadalupe ^a   Solís, Francisco ^a   Casal, Manuel ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL LABORATORY; COLORIMETRY; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; COLORIMETRY; MICROBIAL SENSITIVITY TESTS; MYCOLOGY; PYRIMIDINES; SENSITIVITY AND SPECIFICITY; TRIAZOLES;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; ISSATCHENKIA ORIENTALIS;

EID: 1242336845     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.2.899-902.2004     Document Type: Article

References (20)

1. Arikan, S., D. Gür, and M. Akova. 1997. Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 40:291-296.
2. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
3. Chandrasekar, P. H., and E. Manavathu. 2001. Voriconazole: a second-generation triazole. Drugs Today 37:135-148.
4. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
5. Espinel-Ingroff, A. 1998. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol. 36:198-202.
6. Espinel-Ingroff, A., M. Pfaller, S. A. Messer, C. C. Knapp, S. Killian, H. A. Norris, and M. A. Ghannoum. 1999. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeast-like organisms. J. Clin. Microbiol. 37:591-595.
7. Espinel-Ingroff, A., D. W. Warnock, J. A. Vazquez, and B. A. Arthington-Skaggs. 2000. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med. Mycol. 38:293-304.
8. Hoban, D. J., G. G. Zhanel, and J. A. Karlowsky. 1999. In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients. Antimicrob. Agents Chemother. 43:1463-1464.
9. Linares, M. J., J. F. Muñoz, F. Solís, F. C. Rodríguez, A. Valero, and M. Casal. 1998. Study of susceptibility of yeast isolates of clinical interest to five antifungal agents using the E-test. Rev. Esp. Quimioter. 11:64-69.
10. Linares, M. J., and F. Solis. 2001. Identificación de levaduras, p. 11-1-11-18. In J. Pemán, E. Martin-Mazuelos, and M. C. Rubio-Calvo (ed.), Guia práctica de identificación en micología clínica, 1st ed. Revista Iboamericana de Micologia, Bilbao, Spain.
11. Marco, F., M. A. Pfaller, S. Messer, and R. N. Jones. 1998. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 42:161-163.
12. Messer, S. A., and M. A. Pfaller. 1996. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing. Diagn. Microbiol. Infect. Dis. 25:77-81.
13. Morace, G., G. Amato, F. Bistoni, G. Fadda, P. Marone, M. T. Montagna, S. Oliveri, L. Polonelli, R. Rigoli, L. Mancuso, S. La Face, L. Masucci, L. Romano, C. Napoli, D. Tatò, M. G. Buscema, C. M. C. Belli, M. M. Piccirillo, S. Conti, S. Covan, F. Fanti, C. Cavanna, F. D'Aló, and L. Pitzurra. 2002. Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J. Clin. Microbiol. 40:2953-2958.
14. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Second edition, document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Pfaller, M. A., Q. Vu, M. Lancaster, A. Espinel-Ingroff, A. Fothergill, C. Grant, M. R. McGinnis, L. Pasarell, M. G. Rinaldi, and L. Steele-Moore. 1994. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1625-1628.
16. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
17. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, R. N. Jones, and the International Fungal Surveillance Participant Group. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:78-83.
18. Posteraro, B., L. Romano, M. Sanguinetti, G. Morace, and G. Fadda. 2000. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method. Diagn. Microbiol. Infect. Dis. 38:29-36.
19. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
20. Simon, D. M., and S. Levin. 2001. Infectious complications of solid organ transplantations. Infect. Dis. Clin. N. Am. 15:521-549.